11 Best Very Cheap Stocks to Buy According to Hedge Funds
US equity markets are hovering near record highs, with valuations stretched well above long-term norms.
Insider Monkey Blog
NVIDIA Corporation (NVDA) Grapples With China’s H20 Chip Restrictions; Invests in Nuro’s $203 Million Autonomous Driving Fundraise
With significant upside potential, NVIDIA Corporation (NASDAQ:NVDA) secures a spot on our list of the 12 Best Quantum Computing Stocks to Buy According to Wall Street Analysts...
Cantor Fitzgerald Raises PT on Lam Research Corporation (LRCX) to $120; Maintains ‘Buy’ Rating
With significant upside potential, Lam Research Corporation (NASDAQ:LRCX) secures a spot on our list of the 12 Best Quantum Computing Stocks to Buy According to Wall Street Analysts...
Benchmark Reaffirms ‘Buy’ Rating on Veeco Instruments Inc. (VECO); Sets $28 PT
[caption id="attachment_1420244" align="aligncenter" width="2309"] Close-up of Silicon Die are being Extracted from Semiconductor Wafer and Attached to Substrate by Pick and Place...
TD Cowen Raises PT on Advanced Micro Devices, Inc. (AMD) to $195; Maintains ‘Buy’ Rating
On August 6, 2025, TD Cowen raised its price target for Advanced Micro Devices, Inc.
Honeywell International Inc. (HON) Announces Acquisition of Three Utility Platforms from SparkMeter, Inc.
With significant upside potential, Honeywell International Inc.
Citi Downgrades FormFactor, Inc. (FORM) to ‘Neutral’; Stifel Reaffirms ‘Hold’ Rating
Citi downgraded FormFactor, Inc. (NASDAQ:FORM) to Neutral from Buy on August 21, 2025, and lowered its price target from $36 to $31.
TD Cowen Reiterates ‘Buy’ Rating on SkyWater Technology, Inc. (SKYT)
[caption id="attachment_1420244" align="aligncenter" width="2309"] Close-up of Silicon Die are being Extracted from Semiconductor Wafer and Attached to Substrate by Pick and Place...
Microsoft Corporation (MSFT) Announces its Quantum Safe Program Strategy; UBS Reaffirms ‘Buy’ Rating With $650 PT
With significant upside potential, Microsoft Corporation (NASDAQ:MSFT) secures a spot on our list of the 12 Best Quantum Computing Stocks to Buy According to Wall Street Analysts...
JPMorgan Reduces PT on Endava plc (DAVA); Morgan Stanley Reiterates ‘Hold’ Rating
On August 20, 2025, JPMorgan reduced its price target on Endava plc (NYSE:DAVA) to $17 from $18 while maintaining a Neutral rating, citing the sector’s third consecutive year...
Rigetti Computing, Inc. (RGTI) Collaborates With Montana State University, launching QCORE; Cantor Fitzgerald Raises PT to $18
With significant upside potential, Rigetti Computing, Inc.
IonQ, Inc. (NYSE:IONQ) Reports Significant Advances in its Intellectual Property Portfolio
On August 20, 2025, IonQ (NYSE: IONQ) reported significant advances in its intellectual property portfolio, highlighted by newly issued U.S.
Piper Sandler Raises PT on D-Wave Quantum Inc. (QBTS) to $22; Maintains ‘Overweight’ Rating
On August 8, 2025, Piper Sandler raised its price target for D-Wave Quantum Inc. (NYSE:QBTS) to $22 from $13, keeping its Overweight rating.
Kyndryl Holdings, Inc. (KD) Signs the White House’s Pledge to America’s Youth: Investing in AI Education
With a strong EPS growth estimate for the next year and significant hedge fund interest, Kyndryl Holdings, Inc.
Jefferies Raises PT on Wayfair Inc. (W) to $91, Maintains ‘Buy’ Rating
On August 20, 2025, Jefferies raised its price target on Wayfair Inc.
Cantor Fitzgerald Maintains Overweight Rating on SentinelOne, Inc. (S) With $24 PT
With a strong EPS growth estimate for the next year and significant hedge fund interest, SentinelOne, Inc.
Cantor Fitzgerald Reaffirms ‘Overweight’ Rating on Sandisk Corporation (SNDK) With $50 PT
On August 15, 2025, Cantor Fitzgerald confirmed its Overweight rating and $50 price target for Sandisk Corporation (NASDAQ:SNDK) following the company’s excellent June-quarter...
KeyBanc Raises PT on Remitly Global, Inc. (RELY) to $28, Maintains ‘Overweight’ Rating
With a strong EPS growth estimate for the next year and significant hedge fund interest, Remitly Global, Inc.
Truist Securities Raises PT on Etsy, Inc. (ETSY) to $75, Maintains ‘Buy’ Rating
On August 20, 2025, Truist Securities boosted its price target for Etsy, Inc. (NASDAQ:ETSY) to $75 from $70, retaining a Buy rating based on positive Truist Card Data signals.
JPMorgan Reaffirms ‘Buy’ Rating on Microchip Technology Incorporated (MCHP) With $92.50 PT
With a strong EPS growth estimate for the next year and significant hedge fund interest, Microchip Technology Incorporated (NASDAQ:MCHP) secures a spot on our list of the 15 Stocks...
TD Cowen Maintains ‘Buy’ Rating on Lyft, Inc. (LYFT) With $22 PT
On August 19, 2025, TD Cowen reiterated its Buy rating and $22 price target for Lyft, Inc.
Affirm Holdings, Inc. (AFRM) Extends Partnership With Stripe; RBC Capitals Maintains ‘Sector Perform’ Rating
With a strong EPS growth estimate for the next year and significant hedge fund interest, Affirm Holdings, Inc.
Truist Securities Raises PT on Toast, Inc. (TOST) to $51, Maintains ‘Buy’ Rating
Citing robust second-quarter earnings momentum, Truist Securities raised its price target on Toast, Inc.
Argus Research Initiates Coverage on Reddit, Inc. (RDDT) With $250 PT; Deutsche Bank Raises PT to $205
With a strong EPS growth estimate for the next year and significant hedge fund interest, Reddit, Inc.
Morgan Stanley Raises PT on Coupang, Inc. (CPNG) to $35; Maintains ‘Overweight’ Rating
Following the company’s impressive second-quarter results, Morgan Stanley raised its price target on Coupang, Inc.
DoorDash, Inc. (DASH) Talks AI Integration Amid EU Review of Deliveroo Acquisition Plans
With a strong EPS growth estimate for the next year and significant hedge fund interest, DoorDash, Inc.
Intel Corporation (INTC) Talks about New Xeon 6 Processors; Bank of American Reaffirms ‘Neutral’ Rating
Intel Corporation (NASDAQ:INTC) said on August 20 that its new Xeon 6 processors, which provide industry-leading memory bandwidth and performance for workloads driven by AI and...
Barclays Reaffirms ‘Overweight’ Rating on Micron Technology, Inc. (MU) With $140 PT
With a strong EPS growth estimate for the next year and significant hedge fund interest, Micron Technology, Inc.
Genmab A/S (GMAB)’s Epcoritamab Delivers 95% Response in Lymphoma
Genmab A/S (NASDAQ:GMAB), a Danish biotechnology leader, specializes in antibody-based therapies for cancer and serious diseases, with notable successes including Darzalex (daratumumab...
Sanofi (SNY)’s Sarclisa Gets EMA Nod for Multiple Myeloma
Sanofi (NASDAQ:SNY) is a global biopharmaceutical company focused on innovative medicines and vaccines, with active efforts in oncology, immunology, and rare diseases.
MiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy
MiMedx Group, Inc. (NASDAQ:MDXG) is a biotechnology company based in Marietta, Georgia, specializing in regenerative biologics for advanced wound care and surgical recovery.
MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza
MannKind Corporation (NASDAQ:MNKD) is a biopharmaceutical company developing inhaled therapeutic products for endocrine and orphan lung diseases.
Ardelyx, Inc. (ARDX) Strengthens Global Reach with Kyowa Kirin Deal
Ardelyx, Inc. (NASDAQ:ARDX) stands fourth on our list among the best biotech stocks.
Xeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 Revenue
Xeris Biopharma Holdings, Inc.
Wave Life Sciences Ltd. (WVE) Gains Momentum With Multiple RNA Wins
Wave Life Sciences Ltd. (NASDAQ:WVE) is a Singapore-based clinical-stage biotechnology company developing RNA-based therapies using its proprietary PRISM platform.
Amicus Therapeutics, Inc. (FOLD) Expands Pipeline With Rare Kidney Disease Drug
Amicus Therapeutics, Inc. (NASDAQ:FOLD) tops our list for being one of the best biotech stocks.
Collegium Pharmaceutical, Inc. (COLL) Highlights Real-World Evidence at PAINWeek 2025
Collegium Pharmaceutical, Inc.
Ardent Health, Inc. (ARDT) Expands Footprint with 18 New Urgent Care Clinics in 2025
Ardent Health, Inc. (NYSE:ARDT), one of the most overlooked stocks, is rapidly expanding its presence in the U.S.
Integra LifeSciences Holdings Corporation (IART) Focuses on Supply Chain Recovery and Growth Strategy
Integra LifeSciences Holdings Corporation (NASDAQ:IART), based in Princeton, New Jersey, is a medical device company specializing in neurosurgery, wound care, otolaryngology, ...
Bausch Health Companies Inc. (BHC) Expands Hepatology Portfolio with DURECT Acquisition
In Q2 2025, Bausch Health Companies Inc.
Royalty Pharma plc (RPRX) Boosts Growth with $885M Amgen Imdelltra Royalty Deal
Royalty Pharma plc (NASDAQ:RPRX) is a leading buyer of biopharmaceutical royalties, holding interests in over 35 commercial products, including Trikafta, Trelegy, Evrysdi, and...
Organon & Co. (OGN) Advances VTAMA Cream, Strengthens Women’s Health Portfolio
Organon & Co. (NYSE:OGN) is a pharmaceutical company focused on women’s health and biosimilars.
Jazz Pharmaceuticals plc (JAZZ) Wins FDA Accelerated Approval for Modeyso™ Brain Cancer Therapy
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a specialty pharmaceutical company focused on neuroscience, oncology, and rare diseases, with a global presence and products including...
Teva Pharmaceutical Industries Limited (TEVA) Gains FDA Nod for Pediatric Migraine Drug AJOVY
Teva Pharmaceutical Industries Limited (NYSE:TEVA) tops our list for being one of the overlooked stocks.
Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally
Genmab A/S (NASDAQ:GMAB), based in Copenhagen, is a biotechnology company focused on developing antibody-based therapies for cancer and other serious diseases.
Harmony Biosciences Holdings, Inc. (HRMY) Expands WAKIX With FDA Nod for Prader-Willi
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a commercial-stage biopharmaceutical company focused on therapies for rare neurological diseases.
Agios Pharmaceuticals, Inc. (AGIO) Advances Pipeline With Tebapivat, AG-236 in Rare Blood Disorders
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is a commercial-stage biopharmaceutical company focused on therapies for rare diseases, particularly in cellular metabolism.
Hedge Fund Resource Center
